These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 9503259

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia.
    Fleischhaker C, Schulz E, Remschmidt H.
    J Psychiatr Res; 1998; 32(5):325-33. PubMed ID: 9789212
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Correlated changes in symptoms and neurotransmitter indices during maintenance treatment with clozapine or conventional neuroleptics in adolescents and young adults with schizophrenia.
    Schulz E, Fleischhaker C, Remschmidt HE.
    J Child Adolesc Psychopharmacol; 1996; 6(2):119-31. PubMed ID: 9231304
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
    Spina E, Avenoso A, Facciolà G, Scordo MG, Ancione M, Madia AG, Ventimiglia A, Perucca E.
    Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuroleptic-resistant schizophrenic patients treated by clozapine: clinical evolution, plasma and red blood cell clozapine and desmethylclozapine levels.
    Aymard N, Baldacci C, Leyris A, Smagghe PO, Tribolet S, Vacheron MN, Viala A, Caroli F.
    Therapie; 1997 Jan; 52(3):227-32. PubMed ID: 9366107
    [Abstract] [Full Text] [Related]

  • 12. Clozapine response and plasma catecholamines and their metabolites.
    Green AI, Alam MY, Sobieraj JT, Pappalardo KM, Waternaux C, Salzman C, Schatzberg AF, Schildkraut JJ.
    Psychiatry Res; 1993 Feb; 46(2):139-49. PubMed ID: 8483973
    [Abstract] [Full Text] [Related]

  • 13. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
    Shaw P, Sporn A, Gogtay N, Overman GP, Greenstein D, Gochman P, Tossell JW, Lenane M, Rapoport JL.
    Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
    [Abstract] [Full Text] [Related]

  • 14. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP, Poonkuzhali B, Kuruvilla A, Jacob M, Jacob KS.
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations.
    Llorca PM, Lancon C, Disdier B, Farisse J, Sapin C, Auquier P.
    J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974
    [Abstract] [Full Text] [Related]

  • 16. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
    Breier AF, Malhotra AK, Su TP, Pinals DA, Elman I, Adler CM, Lafargue RT, Clifton A, Pickar D.
    Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
    [Abstract] [Full Text] [Related]

  • 17. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S, Lieberman J, Pollack S, Kane JM, Safferman A, Munne R, Umbricht D, Woerner M, Masiar S, Kronig M.
    Biol Psychiatry; 1996 Feb 15; 39(4):249-54. PubMed ID: 8645771
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
    Brown AS, Gewirtz G, Harkavy-Friedman J, Cooper T, Brébion G, Amador XF, Malaspina D, Gorman JM.
    Neuropsychopharmacology; 1997 Nov 15; 17(5):317-25. PubMed ID: 9348547
    [Abstract] [Full Text] [Related]

  • 20. An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia.
    Turetz M, Mozes T, Toren P, Chernauzan N, Yoran-Hegesh R, Mester R, Wittenberg N, Tyano S, Weizman A.
    Br J Psychiatry; 1997 Jun 15; 170():507-10. PubMed ID: 9330014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.